Heart Test Laboratories, Inc. (HSCS)
USD 3.76
(-2.21%)
USD 3.76
(-2.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.07 Million | -5.77 Million | -3.64 Million | -2.45 Million | -3.83 Million |
| Net Income | -6.6 Million | -6.35 Million | -4.82 Million | -2.45 Million | -3.81 Million |
| Depreciation & Amortization | 95.13 Thousand | 26.91 Thousand | 26.56 Thousand | 33.61 Thousand | 63.82 Thousand |
| Deferred income taxes | - | 101.09 Million | - | - | -10.01 Thousand |
| Stock-based compensation | 405.02 Thousand | 248.3 Thousand | 68.39 Thousand | 24.67 Thousand | 135.06 Thousand |
| Change in working capital | -504.36 Thousand | 173.98 Thousand | 1.12 Million | 190.12 Thousand | -195.96 Thousand |
| Other non-cash items | 539.22 Thousand | -100.96 Million | -35.59 Thousand | -248.53 Thousand | -21.79 Thousand |
| Investing Cash Flow | -125.27 Thousand | -18.3 Thousand | -1932.00 | -712.00 | 8167.00 |
| Investments in PPE | -125.27 Thousand | -18.3 Thousand | -1932.00 | -712.00 | -11.42 Thousand |
| Acquisitions | - | - | - | - | 19.59 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -60.81 Million | - | - | - | 19.59 Thousand |
| Financing Cash Flow | 10.34 Million | 6.53 Million | 3.84 Million | 2.67 Million | 1.81 Million |
| Debt repayment | -42.62 Thousand | -398.26 Thousand | -500 Thousand | -2.47 Million | -16.97 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 10.3 Million | 5.62 Million | 555.76 Million | 200 Thousand | 585.00 |
| Other Financing Activities | 10.63 Million | 1.3 Million | -551.42 Million | 4.95 Million | 1.82 Million |
| Accounts receivables | - | 2321.00 | -2321.00 | - | -7000.00 |
| Accounts payables | -183.18 Thousand | 37.82 Thousand | 358.96 Thousand | -20.65 Thousand | -305.93 Thousand |
| Inventory | 47.18 Thousand | -2220.00 | 76.63 Thousand | 106.23 Thousand | 147.31 Thousand |
| Other working capital | -517.06 Thousand | 136.05 Thousand | 691.46 Thousand | 104.54 Thousand | -30.34 Thousand |
| Cash at beginning of period | 1.66 Million | 918.26 Thousand | 723.48 Thousand | 496.85 Thousand | 2.51 Million |
| Cash at end of period | 5.8 Million | 1.66 Million | 918.26 Thousand | 723.48 Thousand | 496.85 Thousand |
| Capital Expenditure | -125.27 Thousand | -18.3 Thousand | -1932.00 | -712.00 | -11.42 Thousand |
| Effect of forex changes on cash | - | 1.73 Billion | - | - | - |
| Net cash flow / Change in cash | 4.14 Million | 742.2 Thousand | 194.77 Thousand | 226.62 Thousand | -2.02 Million |
| Free Cash Flow | -6.19 Million | -5.79 Million | -3.64 Million | -2.45 Million | -3.85 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.6 Million | -1.84 Million | -1.64 Million | -1.74 Million | -1.36 Million | -1.63 Million |
| Depreciation & Amortization | 95.13 Thousand | 76.44 Thousand | 3717.00 | 7636.00 | 7338.00 | 6825.00 |
| Deferred income taxes | - | -1.32 Billion | -782.98 Thousand | - | 1.32 Billion | - |
| Stock-based compensation | 405.02 Thousand | 78.44 Thousand | 96.09 Thousand | 105.84 Thousand | 124.64 Thousand | 99.15 Thousand |
| Change in working capital | -504.36 Thousand | 54.89 Thousand | -721.09 Thousand | 331.22 Thousand | -169.39 Thousand | -486.65 Thousand |
| Other non-cash items | 539.22 Thousand | 100 Thousand | 906.72 Thousand | 315.49 Thousand | -1.32 Billion | 151.32 Thousand |
| Investing Cash Flow | -125.27 Thousand | -109.61 Thousand | -8794.00 | -1952.00 | -4910.00 | -7592.00 |
| Investments in PPE | -125.27 Thousand | -109.61 Thousand | -8794.00 | -1952.00 | -4910.00 | -7592.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -60.81 Million | -60.81 Thousand | - | - | - | - |
| Financing Cash Flow | 10.34 Million | 377.14 Thousand | 9.12 Million | 514.62 Thousand | 324.36 Thousand | 1.59 Million |
| Debt repayment | -42.62 Thousand | -74.04 Thousand | -50.43 Thousand | -99.56 Thousand | -67.58 Thousand | -121.53 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.3 Million | 451.18 Thousand | 9.17 Million | 279.94 Thousand | 391.95 Thousand | 429.31 Thousand |
| Other Financing Activities | 10.63 Million | 451.18 Thousand | 9.17 Million | 334.24 Thousand | 324.36 Thousand | 1.29 Million |
| Accounts receivables | - | 14.7 Thousand | -10.8 Thousand | -3900.00 | - | 78.03 Thousand |
| Accounts payables | -183.18 Thousand | 33.1 Thousand | -673.22 Thousand | 633.45 Thousand | -176.52 Thousand | -389.31 Thousand |
| Inventory | 47.18 Thousand | 41.09 Thousand | 4561.00 | 1520.00 | - | 550.00 |
| Other working capital | -517.06 Thousand | -37.4 Thousand | -41.63 Thousand | -299.85 Thousand | 7135.00 | -175.92 Thousand |
| Cash at beginning of period | 1.66 Million | 7.07 Million | 100.14 Thousand | 575.65 Thousand | 1.66 Million | 1.93 Million |
| Cash at end of period | 5.8 Million | 5.8 Million | 7.07 Million | 100.14 Thousand | 575.65 Thousand | 1.66 Million |
| Capital Expenditure | -125.27 Thousand | -109.61 Thousand | -8794.00 | -1952.00 | -4910.00 | -7592.00 |
| Effect of forex changes on cash | - | 37.41 Million | - | - | -37.41 Million | -7.23 Million |
| Net cash flow / Change in cash | 4.14 Million | -1.26 Million | 6.97 Million | -475.51 Thousand | -1.08 Million | -270.48 Thousand |
| Free Cash Flow | -6.19 Million | -1.64 Million | -2.15 Million | -990.13 Thousand | -1.4 Million | -1.86 Million |
2001
VRED
DBRG-PH
AKG
688799
BZDLF